CHIEF FINANCIAL OFFICER
Thu, Jan 2, 2025
Jan 2
exercised or converted securities in ACLX
20,495 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +841.00% (+25,230 shares)
Option Exercise
Sale tied to a same-time option exercise
ACLXArcellx, Inc.
Health CareBiotechnology